Clinical Trial Update: Inflammation Reduction by TREhalose AdminisTration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating trehalose administration for inflammation reduction in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Trehalose (trehalose)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Acute Coronary Syndrome | Phase 2 | Status: UNKNOWN